Family Therapy for Cancer Palliative Care and Bereavement
Trial Summary
What is the purpose of this trial?
The purpose of this study is to learn how well family therapy works if given while a family member is being treated for a serious illness and whether it helps their family to continue meeting for a time after their death. The therapy aims to assist the family communication and support during both palliative care and bereavement. The investigators also want to learn how many family therapy sessions spread out over time are best for helping patients and their families. Patients are randomly assigned to one of three groups: patients who receive standard palliative care, patients and their families who take part in 6 sessions, and patients and their families who take part in 10 sessions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on family therapy and does not mention medication changes.
What data supports the effectiveness of the treatment Family Focused Group Therapy in cancer palliative care and bereavement?
Family Focused Grief Therapy (FFGT) has been shown to help families improve communication, cohesiveness, and conflict management, which can reduce the negative effects of grief. Studies indicate that FFGT is effective in aiding families at high risk of poor functioning during palliative care and bereavement, leading to better family functioning and reduced distress.12345
Is Family Therapy for Cancer Palliative Care and Bereavement safe for humans?
How is Family Focused Group Therapy different from other treatments for cancer palliative care and bereavement?
Family Focused Group Therapy is unique because it targets the entire family rather than just the individual, aiming to improve family communication and functioning during palliative care and into bereavement. It is a structured, time-limited intervention that helps families at high risk of poor psychosocial outcomes by promoting cohesiveness and managing conflicts, which is not typically the focus of other treatments.12356
Research Team
Talia Zaider, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
This trial is for families with a member facing advanced cancer. Eligible participants include those with satisfactory cognitive function to consent and participate in therapy, at least two family members willing to join, and certain scores on a family relationship index. Families must speak English and be geographically able to attend sessions. Children under 12 or individuals with significant psychiatric issues are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Family Focused Grief Therapy sessions are conducted with families of patients with advanced disease
Bereavement Follow-up
Follow-up of family members for psychosocial well-being, perceptions of family functioning, and costs of health-related care
Treatment Details
Interventions
- Family Focused Group Therapy
- Standard of Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Beth Israel Medical Center
Collaborator
Calvary Hospital, Bronx, NY
Collaborator
Monash University
Collaborator